CTLA4 and neoplasm: Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) acts as a brake on the surface of T cells, leading researchers to explore whether blocking CTLA-4 might augment anti-tumor T cell-mediated immunity.